VolumeVol. 64 • Number No. 2 • April - June 2026 Back

Original Article

Prospective Evaluation of the FRAIL Scale as a Predictor of Hospitalization and All-Cause Mortality Among Patients with End-Stage Renal Disease on Hemodialysis

Authors: Melvy June S. Balasa, Mark Raymund A. Rodriguez, Ferdinand Renfred A. Zapata

DOI: 10.65564/pjim.c571e8b191

Date of Publication: June 2026


Abstract

Background. Despite the increased prevalence of frailty and the unfavorable implications that follow, the implementation of frailty assessment has yet to be established in clinical practice. The 5-item FRAIL scale is an easy-to-apply tool that showed a good correlation with age, presence of comorbidities, and dialysis complications. This study aimed to identify the association between frailty severity and clinical outcomes, including death and hospitalizations.

Method. A prospective cohort study was conducted in the outpatient dialysis unit of a private tertiary hospital in Cebu, Philippines. Between October 2023 and September 2024, 160 eligible patients on maintenance hemodialysis were evaluated for frailty. Clinicodemographic parameters were retrieved. Comparative analyses were performed using chi-square tests and one-way ANOVA with post hoc analysis. Binary logistic regression analysis was conducted to determine significant associations between outcomes and frailty scores.

Results. The majority of patients were categorized as pre-frail, 53.13% (n=85), with a mean age of 59.28 ± 14.50 years, compared to frail patients (28.13%, n=45), who had a significantly higher mean age of 66.16 ± 14.04 years. Regression analysis demonstrated that heart failure, cancer, and coronary artery disease/ischemic heart disease were significantly associated with frailty.

Conclusion. Mortality significantly increased with frailty severity (3.33% of non-frail, 12.94% of pre-frail, and 40% of frail patients). Among the components of the FRAIL scale, ambulation challenges, illness, and weight loss in CKD patients undergoing hemodialysis were identified to have significant burdens and implicate areas for targeted interventions.

Keywords. FRAIL scale, Frailty, Chronic Kidney Disease, Hemodialysis, mortality, hospitalization


References

  1. Philippines Life Expectancy 1950-2023. www.macrotrends.net. Retrieved 2023-07-18.
  2. McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG et al. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 2013; 61: 896– 901.
  3. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487–1492. doi: 10.1111/j.1532-5415.2012.04054.
  4. Chowdhury R, Peel NM, Krosch M, Hubbard RE. Frailty and chronic kidney disease: a systematic review. Arch Gerontol Geriatr. 2017;68:135–142. doi: 10.1016/J.ARCHGER.2016.10.007
  5. Marcello Tonelli. Natasha Wiebe. John S. Gill. Aminu K. Bello. Brenda R. Hemmelgarn. Christopher T. Chan, Anita Lloyd, Ravi I. Thadhani, and Stephanie Thompson. Frailty and Clinical Outcomes in Patients Treated With Hemodialysis: A Prospective Cohort Study. Kidney Med Vol 5, Issue 8, August 2023.
  6. Rockwood K, Andrew M, Mitnitski A Unconventional views of frailty a comparison of two approaches to measuring frailty in older adults; 2007. Available from: http://biomedgerontology.oxfordjournals.org/. Accessed August 6, 2019.
  7. Barbosa, E. M. S., Pereira, A. G., Mori, V., da Silva Neves, R., Vieira, N. M., Silva, M. Z. C., Seki, M. M., Rodrigues, H. C. N., Costa, N. A., Ponce, D., Balbi, A. L., Zornoff, L. A. M., Azevedo, P. S., Polegato, B. F., de Paiva, S. A. R., Minicucci, M. F., & de Souza Dorna, M. (2022). Comparison between FRAIL Scale and Clinical Frailty Scale in predicting hospitalization in hemodialysis patients. Journal of Nephrology, 36(3), 687–693. https://doi.org/10.1007/s40620-022-01532-5
  8. Chao CT, Hsu YH, Chang PY, et al. (2015). A simple self-report FRAIL Scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrol Carlton Vic 20(5):321–32 https://doi.org/10.1111/nep.12401
  9. Moorthi RN, Avin KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 2017; 26: 219–28.
  10. Lee, H.-J., & Son, Y.-J. (2021). Prevalence and Associated Factors of Frailty and Mortality in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 18(7), 3471. https://doi.org/3390/ijerph18073471
  11. Worthen, G., & Tennankore, K. (2019). Frailty Screening in Chronic Kidney Disease: Current Perspectives. International Journal of Nephrology and Renovascular Disease, Volume 12, 229–239. https://doi.org/10.2147/IJNRD.S228956
  12. Kelsey et al., Methods in Observational Epidemiology 2nd Edition, Table 12-15
  13. Kennard, A., Glasgow, N., Rainsford, S., & Talaulikar, G. (2023). Frailty in chronic kidney disease: Challenges in nephrology practice. A review of current literature. Internal Medicine Journal, 53(4), 465–472. https://doi.org/10.1111/imj.15759
  14. Lertdumrongluk P, Rhee CM, Park J. et al. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr 2013; 23: 411–421
  15. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008 Dec;88(6):1511-8. doi: 10.3945/ajcn.2008.26665. PMID: 19064510; PMCID: PMC5500249.
  16. Berger, J. R., Jaikaransingh, V., & Hedayati, S. S. (2016). End-Stage Kidney Disease in the Elderly: Approach to Dialysis Initiation, Choosing Modality, and Predicting Outcomes. Advances in Chronic Kidney Disease, 23(1), 36–43. https://doi.org/10.1053/j.ackd.2015.08.005
  17. Garcia-Canton, C., Rodenas, A., Lopez-Aperador, C., Rivero, Y., Anton, G., Monzon, T., Diaz, N., Vega, N., Loro, J. F., Santana, A., & Esparza, N. (2019). Frailty in hemodialysis and prediction of poor short-term outcome: Mortality, hospitalization, and visits to hospital emergency services. Renal Failure, 41(1), 567–575. https://doi.org/10.1080/0886022X.2019.1628061
  18. Clark, D. A., Khan, U., Kiberd, B. A., Turner, C. C., Dixon, A., Landry, D., Moffatt, H. C., Moorhouse, P. A., & Tennankore, K. K. (2017). Frailty in end-stage renal disease: Comparing patient, caregiver, and clinician perspectives. BMC Nephrology, 18(1), 148. https://doi.org/10.1186/s12882-017-0558-x
  19. Arias-Guillén, M., Romano, B., Yuguero-Ortiz, A., López-Lazcano, A., Guerrero, S., Villegas, V., Martínez, M., Clemente, N., Gómez, M., Rodas, L., Broseta, J. J., Quintela, M., Maduell, F., & Bayés, B. (2023). Frailty in hemodialysis patients: Results of a screening program and multidisciplinary interventions. Clinical Kidney Journal, sfad115. https://doi.org/10.1093/ckj/sfad115
  20. Fleiss, Statistical Methods for Rates and Proportions, formulas 3.18 &3.19
  21. Morley JE, Malmstrom TK, Miller DK (2012). A simple frailty questionnaire (FRAIL) predicts outcomes in middle-aged African Americans. J Nutr Health Aging 16(7):601–608. https://doi. org/10.1007/s12603-012-0084-2
  22. Nair, D., Liu, C. K., Raslan, R., McAdams-DeMarco, M., & Hall, R. K. (2024). Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications. American Journal of Kidney Diseases, S0272638624008369. https://doi.org/10.1053/j.ajkd.2024.04.018
  23. Johansen, K. L., Dalrymple, L. S., Delgado, C., Chertow, G. M., Segal, M. R., Chiang, J., Grimes, B., & Kaysen, G. A. (2017). Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clinical Journal of the American Society of Nephrology, 12(7), 1100–1108. https://doi.org/10.2215/CJN.12131116